Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study-Reference-Cited by-同舟云学术

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

Published:2012-04-30 Issue:1 Volume:12 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Gori Stefania,Clavarezza Matteo,Siena Salvatore,Foglietta Jennifer,Tarenzi Emiliana,Giordano Monica,Molino Annamaria,Graiff Claudio,Fusco Vittorio,Alabiso Oscar,Baldini Editta,Gamucci Teresa,Altavilla Giuseppe,Dondi Davide,Venturini Marco

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-12-158.pdf

Reference45 articles.

1. Grande E, Inghelmann R, Francisci S, Verdecchia A, Micheli A, Baili P, Capocaccia R, De Angelis R: Regional estimates of breast cancer burden in Italy. Tumori. 2007, 93 (4): 374-379.

2. Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003, 39 (12): 1718-1729. 10.1016/S0959-8049(03)00118-7.

3. Glass AG, Lacey JV, Carreon JD, Hoover RN: Breast cancer incidence, 1980–2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007, 99: 1152-1161. 10.1093/jnci/djm059.

4. Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46: 765-781. 10.1016/j.ejca.2009.12.014.

5. Vacek PM, Geller BM, Weaver DL, Foster RS: Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975–1999. Cancer. 2002, 94: 2160-2168. 10.1002/cncr.10459.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer T1 in an emerging country: 325 Tunisian cases;The Breast Journal;2020-10-13

2. Adjuvant chemotherapy for small, lymph node–negative, triple‐negative breast cancer: A single‐center study and a meta‐analysis of the published literature;Cancer;2020-07-25

3. Would 1.0 cm be a more suitable cutoff to subdivide pT1 tumors in hormone receptor-negative and HER2-positive breast cancer?;Cancer Medicine;2018-10-01

4. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study;European Journal of Cancer;2018-01

5. Management of small T1a/b breast cancer by tumor subtype;Breast Cancer Research and Treatment;2017-02-23